Ashley S Cha-Silva

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Bone Mineral Density

Glycemic Control

Metastatic Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

Patient preference and adherence

Healthcare (Basel, Switzerland)

Future oncology (London, England)

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Adam M Brufsky, Martine C Maculaitis, Lewis Kopenhafer, Patrick Olsen, Samantha K Kurosky, Lillian Shahied Arruda, Wendy Heck, Ashley S Cha-Silva
Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices. Future oncology (London, England) (2024)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Manuela di Fusco, Joseph C Cappelleri, Laura Anatale-Tardiff, Henriette Coetzer, Alon Yehoshua, Mary B Alvarez, Kristen E Allen, Thomas M Porter, Laura Puzniak, Ashley S Cha-Silva, Santiago M C Lopez, Xiaowu Sun
Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US. Healthcare (Basel, Switzerland) 11 (20) (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Melody Zhao, Kent A Hanson, Yixie Zhang, Anna Zhou, Ashley S Cha-Silva
Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review. Targeted oncology (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)